tiprankstipranks
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (HK:2315)
:2315
Hong Kong Market
2315
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
RESEARCH TOOLSreports

Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (2315) Ratios

1 Followers

Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H Ratios

HK:2315's free cash flow for Q2 2025 was ¥0.78. For the 2025 fiscal year, HK:2315's free cash flow was decreased by ¥ and operating cash flow was ¥0.16. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
 1.89 1.53 1.25 1.52 1.96
Quick Ratio
 1.87 1.33 1.23 1.36 1.77
Cash Ratio
 1.02 0.71 0.69 1.00 1.04
Solvency Ratio
 0.17 0.13 -0.12 -0.28 -0.40
Operating Cash Flow Ratio
 0.82 0.39 -0.13 -0.50 -0.82
Short-Term Operating Cash Flow Coverage
 2.50 1.01 -0.43 -2.39 0.00
Net Current Asset Value
¥ -701.56M¥ -760.18M¥ -935.92M¥ -729.72M¥ -176.57M
Leverage Ratios
Debt-to-Assets Ratio
 0.25 0.24 0.22 0.15 0.04
Debt-to-Equity Ratio
 0.69 0.68 0.69 0.36 0.07
Debt-to-Capital Ratio
 0.41 0.41 0.41 0.27 0.07
Long-Term Debt-to-Capital Ratio
 0.22 0.19 0.18 0.04 0.00
Financial Leverage Ratio
 2.79 2.90 3.12 2.44 1.85
Debt Service Coverage Ratio
 1.63 0.98 -0.36 -2.55 -9.59
Interest Coverage Ratio
 3.67 1.79 -2.71 -9.45 -12.83
Debt to Market Cap
 0.02 0.13 0.09 0.02 0.00
Interest Debt Per Share
 1.73 1.66 1.62 1.20 0.33
Net Debt to EBITDA
 0.35 0.62 -1.48 0.40 1.00
Profitability Margins
Gross Profit Margin
79.48%77.67%70.59%73.38%69.79%
EBIT Margin
20.48%13.73%-39.10%-113.25%-142.78%
EBITDA Margin
32.12%30.99%-13.65%-87.26%-106.65%
Operating Profit Margin
21.58%16.76%-37.70%-99.36%-142.66%
Pretax Profit Margin
12.56%4.38%-53.03%-112.64%-153.90%
Net Profit Margin
11.10%3.42%-53.42%-112.79%-153.88%
Continuous Operations Profit Margin
11.10%3.42%-53.42%-112.79%-153.90%
Net Income Per EBT
88.36%78.11%100.74%100.13%99.99%
EBT Per EBIT
58.22%26.12%140.65%113.37%107.87%
Return on Assets (ROA)
5.31%1.39%-15.63%-21.51%-23.69%
Return on Equity (ROE)
15.32%4.02%-48.73%-52.53%-43.74%
Return on Capital Employed (ROCE)
12.74%8.74%-14.44%-24.18%-27.25%
Return on Invested Capital (ROIC)
10.32%6.09%-13.03%-22.43%-26.86%
Return on Tangible Assets
5.35%1.40%-15.82%-21.74%-23.75%
Earnings Yield
0.62%1.06%-9.42%-6.77%-6.50%
Efficiency Ratios
Receivables Turnover
 5.92 4.18 5.01 4.96 3.44
Payables Turnover
 2.34 1.90 1.20 0.97 1.05
Inventory Turnover
 31.95 2.11 21.31 1.49 1.29
Fixed Asset Turnover
 0.88 0.73 0.49 0.33 0.25
Asset Turnover
 0.48 0.41 0.29 0.19 0.15
Working Capital Turnover Ratio
 3.40 4.59 3.13 1.44 0.57
Cash Conversion Cycle
 -83.17 67.39 -213.36 -57.58 40.80
Days of Sales Outstanding
 61.63 87.26 72.82 73.62 106.13
Days of Inventory Outstanding
 11.42 172.65 17.13 244.23 283.75
Days of Payables Outstanding
 156.22 192.52 303.31 375.42 349.07
Operating Cycle
 73.05 259.91 89.95 317.85 389.88
Cash Flow Ratios
Operating Cash Flow Per Share
 0.97 0.53 -0.19 -0.77 -0.92
Free Cash Flow Per Share
 0.85 0.44 -0.51 -1.39 -1.42
CapEx Per Share
 0.12 0.09 0.32 0.61 0.50
Free Cash Flow to Operating Cash Flow
 0.88 0.82 2.65 1.79 1.54
Dividend Paid and CapEx Coverage Ratio
 8.30 5.69 -0.61 -1.26 -1.84
Capital Expenditure Coverage Ratio
 8.30 5.69 -0.61 -1.26 -1.84
Operating Cash Flow Coverage Ratio
 0.63 0.37 -0.14 -0.73 -4.07
Operating Cash Flow to Sales Ratio
 0.32 0.22 -0.11 -0.57 -1.03
Free Cash Flow Yield
1.56%5.48%-5.00%-6.12%-6.72%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 161.23 94.73 -10.61 -14.77 -15.40
Price-to-Sales (P/S) Ratio
 18.20 3.24 5.67 16.66 23.69
Price-to-Book (P/B) Ratio
 23.90 3.81 5.17 7.76 6.73
Price-to-Free Cash Flow (P/FCF) Ratio
 63.99 18.25 -19.99 -16.35 -14.88
Price-to-Operating Cash Flow Ratio
 55.36 15.04 -53.02 -29.33 -22.96
Price-to-Earnings Growth (PEG) Ratio
 0.61 -0.87 0.28 -1.36 -0.55
Price-to-Fair Value
 23.90 3.81 5.17 7.76 6.73
Enterprise Value Multiple
 57.01 11.08 -43.00 -18.69 -21.22
Enterprise Value
 21.80B 3.37B 4.21B 8.71B 8.02B
EV to EBITDA
 57.01 11.08 -43.00 -18.69 -21.22
EV to Sales
 18.31 3.43 5.87 16.31 22.63
EV to Free Cash Flow
 64.38 19.33 -20.70 -16.01 -14.21
EV to Operating Cash Flow
 56.62 15.94 -54.91 -28.71 -21.93
Tangible Book Value Per Share
 2.22 2.06 1.91 2.85 3.14
Shareholders’ Equity Per Share
 2.25 2.10 1.97 2.92 3.14
Tax and Other Ratios
Effective Tax Rate
 0.12 0.22 >-0.01 >-0.01 0.00
Revenue Per Share
 3.01 2.46 1.80 1.36 0.89
Net Income Per Share
 0.33 0.08 -0.96 -1.53 -1.38
Tax Burden
 0.88 0.78 1.01 1.00 1.00
Interest Burden
 0.61 0.32 1.36 0.99 1.08
Research & Development to Revenue
 0.31 0.33 0.66 1.31 1.58
SG&A to Revenue
 0.29 0.32 0.40 0.49 0.20
Stock-Based Compensation to Revenue
 0.03 0.02 0.04 0.03 0.08
Income Quality
 2.91 4.92 0.20 0.50 0.67
Currency in CNY